Borrelia burgdorferi PlzA is a cyclic‐di‐GMP dependent DNA and RNA binding protein
Molecular Microbiology · 2024
DOI: 10.1111/mmi.15254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Microbiology, 2024. Verfasst von Nerina Jusufovic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Borrelia burgdorferi, Cyclic GMP, Bacterial Proteins, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The PilZ domain‐containing protein, PlzA, is the only known cyclic di‐GMP binding protein encoded by all Lyme disease spirochetes. PlzA has been implicated in the regulation of many borrelial processes, but the effector mechanism of PlzA was not previously known. Here, we report that PlzA can bind DNA and RNA and that nucleic acid binding requires c‐di‐GMP, with the affinity of PlzA for nucleic acids increasing as concentrations of c‐di‐GMP were increased. A mutant PlzA that is incapable of binding c‐di‐GMP did not bind to any tested nucleic acids. We also determined that PlzA interacts predominantly with the major groove of DNA and that sequence length and G–C content play a role in DNA binding affinity. PlzA is a dual‐domain protein with a PilZ‐like N‐terminal domain linked to a canonical C‐terminal PilZ domain. Dissection of the domains demonstrated that the separated N‐terminal domain bound nucleic acids independently of c‐di‐GMP. The C‐terminal domain, which includes the c‐di‐GMP binding motifs, did not bind nucleic acids under any tested conditions. Our data are supported by computational docking, which predicts that c‐di‐GMP binding at the C‐terminal domain stabilizes the overall protein structure and facilitates PlzA‐DNA interactions via residues in the N‐terminal domain. Based on our data, we propose that levels of c‐di‐GMP during the various stages of the enzootic life cycle direct PlzA binding to regulatory targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
- Department of Biomedical Sciences, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota, USA.
- Department of Microbiology, Molecular Genetics and Immunology, University of Kansas School of Medicine, Kansas City, Kansas, USA.
- Department of Chemistry and Biochemistry, Bates College, Lewiston, Maine, USA.
- Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
- Department of Entomology, University of Kentucky, Lexington, Kentucky, USA.
ORCID-Profile: Wolfram R Zückert, Md A Motaleb, Brian Stevenson
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jusufovic, N., Krusenstjerna, A. C., Savage, C. R., Saylor, T. C., Brissette, C. A., Zückert, W. R., Schlax, P. J., Motaleb, M. A., & Stevenson, B. (2024). Borrelia burgdorferi PlzA is a cyclic‐di‐GMP dependent DNA and RNA binding protein. Molecular Microbiology. https://doi.org/10.1111/mmi.15254
Vancouver
Jusufovic N, Krusenstjerna AC, Savage CR, Saylor TC, Brissette CA, Zückert WR, et al. Borrelia burgdorferi PlzA is a cyclic‐di‐GMP dependent DNA and RNA binding protein. Molecular Microbiology. 2024. doi:10.1111/mmi.15254
BibTeX
@article{Jusufovic2024,
author = {Jusufovic, Nerina and Krusenstjerna, Andrew C and Savage, Christina R and Saylor, Timothy C and Brissette, Catherine A and Zückert, Wolfram R and Schlax, Paula J and Motaleb, Md A and Stevenson, Brian},
title = {Borrelia burgdorferi PlzA is a cyclic‐di‐GMP dependent DNA and RNA binding protein},
journal = {Molecular Microbiology},
year = {2024},
doi = {10.1111/mmi.15254}
}
EUVIMED